首页> 外文期刊>Theranostics >Smooth muscle SIRT1 reprograms endothelial cells to suppress angiogenesis after ischemia
【24h】

Smooth muscle SIRT1 reprograms endothelial cells to suppress angiogenesis after ischemia

机译:平滑肌SIRT1重新编程内皮细胞以在缺血后抑制血管生成

获取原文
           

摘要

Objective: Vascular smooth muscle cells (VSMCs) undergo the phenotypic changes from contractile to synthetic state during vascular remodeling after ischemia. SIRT1 protects against stress-induced vascular remodeling via maintaining VSMC differentiated phenotype. However, the effect of smooth muscle SIRT1 on the functions of endothelial cells (ECs) has not been well clarified. Here, we explored the role of smooth muscle SIRT1 in endothelial angiogenesis after ischemia and the underlying mechanisms. Methods: We performed a femoral artery ligation model using VSMC specific human SIRT1 transgenic (SIRT1-Tg) and knockout (KO) mice. Angiogenesis was assessed in in vivo by quantification of the total number of capillaries, wound healing and matrigel plug assays, and in vitro ECs by tube formation, proliferation and migration assays. The interaction of HIF1α with circRNA was examined by using RNA immunoprecipitation, RNA pull-down and in situ hybridization assays. Results: The blood flow recovery was significantly attenuated in SIRT1-Tg mice, and markedly improved in SIRT1-Tg mice treated with SIRT1 inhibitor EX527 and in SIRT1-KO mice. The density of capillaries significantly decreased in the ischemic gastrocnemius of SIRT1-Tg mice compared with SIRT1-KO and WT mice, with reduced expression of VEGFA, which resulted in decreased number of arterioles. We identified that the phenotypic switching of SIRT1-Tg VSMCs was attenuated in response to hypoxia, with high levels of contractile proteins and reduced expression of the synthetic markers and NG2, compared with SIRT1-KO and WT VSMCs. Mechanistically, SIRT1-Tg VSMCs inhibited endothelial angiogenic activity induced by hypoxia via the exosome cZFP609. The cZFP609 was delivered into ECs, and detained HIF1α in the cytoplasm via its interaction with HIF1α, thereby inhibiting VEGFA expression and endothelial angiogenic functions. Meantime, the high cZFP609 expression was observed in the plasma of the patients with atherosclerotic or diabetic lower extremity peripheral artery disease, associated with reduced ankle-brachial index. Knockdown of cZFP609 improved blood flow recovery after hindlimb ischemia in SIRT1-Tg mice. Conclusions: Our findings demonstrate that SIRT1 may impair the plasticity of VSMCs. cZFP609 mediates VSMCs to reprogram endothelial functions, and serves as a valuable indicator to assess the prognosis and clinical outcomes of ischemic diseases.? The author(s).
机译:目的:血管平滑肌细胞(VSMCs)在缺血后血管重塑过程中与合成状态的表型变化进行。 SIRT1通过维持VSMC差异化表型来保护应力诱导的血管重塑。然而,平滑肌SIRT1对内皮细胞(ECS)功能的影响并未得到很好的澄清。在这里,我们探讨了平滑肌sirt1在缺血和潜在机制后内皮血管生成的作用。方法:使用VSMC特异性人体SIRT1转基因(SIRT1-TG)和敲除(KO)小鼠进行股动脉连接模型。通过定量毛细血管,伤口愈合和基质蛋白塞子测定和通过管形成,增殖和迁移测定的体外ECs评估血管生成。通过使用RNA免疫沉淀,RNA下拉和原位杂交测定来检查HIF1α与CircrNA的相互作用。结果:血流恢复在SIRT1-TG小鼠中显着衰减,并用SIRT1抑制剂EX527和SIRT1-KO小鼠治疗的SIRT1-TG小鼠显着改善。与Sirt1-Ko和Wt小鼠相比,Sirt1-Tg小鼠的缺血性胃肠肿瘤中毛细血管密度显着降低,VEGFA表达降低,导致动脉倍数降低。与SIRT1-KO和WT VSMC相比,我们鉴定了SIRT1-TG VSMCs的表型切换响应于缺氧,并减少了高水平的收缩蛋白并降低了合成标记和NG2的表达。机械地,SIRT1-TG VSMCS通过外泌体CZFP609抑制缺氧诱导的内皮血管生成活性。将CZFP609递送到ECS中,并通过其与HIF1α的相互作用释放细胞质中的HIF1α,从而抑制VEGFA表达和内皮血管生成功能。同时,在动脉粥样硬化或糖尿病下肢周围动脉疾病的患者的血浆中观察到高CZFP609表达,与减少的踝臂指数相关。 CZFP609的敲低改善了SIRT1-TG小鼠后后肢缺血后的血流回收。结论:我们的研究结果表明SIRT1可能会损害VSMC的可塑性。 CZFP609调解VSMC以重新编程内皮功能,并作为评估缺血性疾病预后和临床结果的有价值指标。作者。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号